257 related articles for article (PubMed ID: 23328114)
1. Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.
Mohan P; Castellsague J; Jiang J; Allen K; Chen H; Nemirovsky O; Spyra M; Hu K; Kluwe L; Pujana MA; Villanueva A; Mautner VF; Keats JJ; Dunn SE; Lazaro C; Maxwell CA
Oncotarget; 2013 Jan; 4(1):80-93. PubMed ID: 23328114
[TBL] [Abstract][Full Text] [Related]
2. Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.
Patel AV; Eaves D; Jessen WJ; Rizvi TA; Ecsedy JA; Qian MG; Aronow BJ; Perentesis JP; Serra E; Cripe TP; Miller SJ; Ratner N
Clin Cancer Res; 2012 Sep; 18(18):5020-30. PubMed ID: 22811580
[TBL] [Abstract][Full Text] [Related]
3. Spatial regulation of Aurora A activity during mitotic spindle assembly requires RHAMM to correctly localize TPX2.
Chen H; Mohan P; Jiang J; Nemirovsky O; He D; Fleisch MC; Niederacher D; Pilarski LM; Lim CJ; Maxwell CA
Cell Cycle; 2014; 13(14):2248-61. PubMed ID: 24875404
[TBL] [Abstract][Full Text] [Related]
4. The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells.
Sehdev V; Peng D; Soutto M; Washington MK; Revetta F; Ecsedy J; Zaika A; Rau TT; Schneider-Stock R; Belkhiri A; El-Rifai W
Mol Cancer Ther; 2012 Mar; 11(3):763-74. PubMed ID: 22302096
[TBL] [Abstract][Full Text] [Related]
5. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
Maxwell CA; Benítez J; Gómez-Baldó L; Osorio A; Bonifaci N; Fernández-Ramires R; Costes SV; Guinó E; Chen H; Evans GJ; Mohan P; Català I; Petit A; Aguilar H; Villanueva A; Aytes A; Serra-Musach J; Rennert G; Lejbkowicz F; Peterlongo P; Manoukian S; Peissel B; Ripamonti CB; Bonanni B; Viel A; Allavena A; Bernard L; Radice P; Friedman E; Kaufman B; Laitman Y; Dubrovsky M; Milgrom R; Jakubowska A; Cybulski C; Gorski B; Jaworska K; Durda K; Sukiennicki G; Lubiński J; Shugart YY; Domchek SM; Letrero R; Weber BL; Hogervorst FB; Rookus MA; Collee JM; Devilee P; Ligtenberg MJ; Luijt RB; Aalfs CM; Waisfisz Q; Wijnen J; Roozendaal CE; ; ; Easton DF; Peock S; Cook M; Oliver C; Frost D; Harrington P; Evans DG; Lalloo F; Eeles R; Izatt L; Chu C; Eccles D; Douglas F; Brewer C; Nevanlinna H; Heikkinen T; Couch FJ; Lindor NM; Wang X; Godwin AK; Caligo MA; Lombardi G; Loman N; Karlsson P; Ehrencrona H; Wachenfeldt Av; ; Barkardottir RB; Hamann U; Rashid MU; Lasa A; Caldés T; Andrés R; Schmitt M; Assmann V; Stevens K; Offit K; Curado J; Tilgner H; Guigó R; Aiza G; Brunet J; Castellsagué J; Martrat G; Urruticoechea A; Blanco I; Tihomirova L; Goldgar DE; Buys S; John EM; Miron A; Southey M; Daly MB; ; Schmutzler RK; Wappenschmidt B; Meindl A; Arnold N; Deissler H; Varon-Mateeva R; Sutter C; Niederacher D; Imyamitov E; Sinilnikova OM; Stoppa-Lyonne D; Mazoyer S; Verny-Pierre C; Castera L; de Pauw A; Bignon YJ; Uhrhammer N; Peyrat JP; Vennin P; Fert Ferrer S; Collonge-Rame MA; Mortemousque I; ; Spurdle AB; Beesley J; Chen X; Healey S; ; Barcellos-Hoff MH; Vidal M; Gruber SB; Lázaro C; Capellá G; McGuffog L; Nathanson KL; Antoniou AC; Chenevix-Trench G; Fleisch MC; Moreno V; Pujana MA
PLoS Biol; 2011 Nov; 9(11):e1001199. PubMed ID: 22110403
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas.
Shigeishi H; Fujimoto S; Hiraoka M; Ono S; Taki M; Ohta K; Higashikawa K; Kamata N
Int J Oncol; 2009 Jun; 34(6):1565-71. PubMed ID: 19424574
[TBL] [Abstract][Full Text] [Related]
7. The cytoskeletal protein RHAMM and ERK1/2 activity maintain the pluripotency of murine embryonic stem cells.
Jiang J; Mohan P; Maxwell CA
PLoS One; 2013; 8(9):e73548. PubMed ID: 24019927
[TBL] [Abstract][Full Text] [Related]
8. Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP).
Maris JM; Morton CL; Gorlick R; Kolb EA; Lock R; Carol H; Keir ST; Reynolds CP; Kang MH; Wu J; Smith MA; Houghton PJ
Pediatr Blood Cancer; 2010 Jul; 55(1):26-34. PubMed ID: 20108338
[TBL] [Abstract][Full Text] [Related]
9. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
Blanco I; Kuchenbaecker K; Cuadras D; Wang X; Barrowdale D; de Garibay GR; Librado P; Sánchez-Gracia A; Rozas J; Bonifaci N; McGuffog L; Pankratz VS; Islam A; Mateo F; Berenguer A; Petit A; Català I; Brunet J; Feliubadaló L; Tornero E; Benítez J; Osorio A; Ramón y Cajal T; Nevanlinna H; Aittomäki K; Arun BK; Toland AE; Karlan BY; Walsh C; Lester J; Greene MH; Mai PL; Nussbaum RL; Andrulis IL; Domchek SM; Nathanson KL; Rebbeck TR; Barkardottir RB; Jakubowska A; Lubinski J; Durda K; Jaworska-Bieniek K; Claes K; Van Maerken T; Díez O; Hansen TV; Jønson L; Gerdes AM; Ejlertsen B; de la Hoya M; Caldés T; Dunning AM; Oliver C; Fineberg E; Cook M; Peock S; McCann E; Murray A; Jacobs C; Pichert G; Lalloo F; Chu C; Dorkins H; Paterson J; Ong KR; Teixeira MR; ; Hogervorst FB; van der Hout AH; Seynaeve C; van der Luijt RB; Ligtenberg MJ; Devilee P; Wijnen JT; Rookus MA; Meijers-Heijboer HE; Blok MJ; van den Ouweland AM; Aalfs CM; Rodriguez GC; Phillips KA; Piedmonte M; Nerenstone SR; Bae-Jump VL; O'Malley DM; Ratner ES; Schmutzler RK; Wappenschmidt B; Rhiem K; Engel C; Meindl A; Ditsch N; Arnold N; Plendl HJ; Niederacher D; Sutter C; Wang-Gohrke S; Steinemann D; Preisler-Adams S; Kast K; Varon-Mateeva R; Gehrig A; Bojesen A; Pedersen IS; Sunde L; Jensen UB; Thomassen M; Kruse TA; Foretova L; Peterlongo P; Bernard L; Peissel B; Scuvera G; Manoukian S; Radice P; Ottini L; Montagna M; Agata S; Maugard C; Simard J; Soucy P; Berger A; Fink-Retter A; Singer CF; Rappaport C; Geschwantler-Kaulich D; Tea MK; Pfeiler G; ; John EM; Miron A; Neuhausen SL; Terry MB; Chung WK; Daly MB; Goldgar DE; Janavicius R; Dorfling CM; van Rensburg EJ; Fostira F; Konstantopoulou I; Garber J; Godwin AK; Olah E; Narod SA; Rennert G; Paluch SS; Laitman Y; Friedman E; ; Liljegren A; Rantala J; Stenmark-Askmalm M; Loman N; Imyanitov EN; Hamann U; ; Spurdle AB; Healey S; Weitzel JN; Herzog J; Margileth D; Gorrini C; Esteller M; Gómez A; Sayols S; Vidal E; Heyn H; ; Stoppa-Lyonnet D; Léoné M; Barjhoux L; Fassy-Colcombet M; de Pauw A; Lasset C; Ferrer SF; Castera L; Berthet P; Cornelis F; Bignon YJ; Damiola F; Mazoyer S; Sinilnikova OM; Maxwell CA; Vijai J; Robson M; Kauff N; Corines MJ; Villano D; Cunningham J; Lee A; Lindor N; Lázaro C; Easton DF; Offit K; Chenevix-Trench G; Couch FJ; Antoniou AC; Pujana MA
PLoS One; 2015; 10(4):e0120020. PubMed ID: 25830658
[TBL] [Abstract][Full Text] [Related]
10. The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo.
Zhou N; Singh K; Mir MC; Parker Y; Lindner D; Dreicer R; Ecsedy JA; Zhang Z; Teh BT; Almasan A; Hansel DE
Clin Cancer Res; 2013 Apr; 19(7):1717-28. PubMed ID: 23403633
[TBL] [Abstract][Full Text] [Related]
11. A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma.
Görgün G; Calabrese E; Hideshima T; Ecsedy J; Perrone G; Mani M; Ikeda H; Bianchi G; Hu Y; Cirstea D; Santo L; Tai YT; Nahar S; Zheng M; Bandi M; Carrasco RD; Raje N; Munshi N; Richardson P; Anderson KC
Blood; 2010 Jun; 115(25):5202-13. PubMed ID: 20382844
[TBL] [Abstract][Full Text] [Related]
12. RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR.
Hatano H; Shigeishi H; Kudo Y; Higashikawa K; Tobiume K; Takata T; Kamata N
Lab Invest; 2011 Mar; 91(3):379-91. PubMed ID: 20956971
[TBL] [Abstract][Full Text] [Related]
13. Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
Kolberg M; Bruun J; Murumägi A; Mpindi JP; Bergsland CH; Høland M; Eilertsen IA; Danielsen SA; Kallioniemi O; Lothe RA
Mol Oncol; 2017 Sep; 11(9):1156-1171. PubMed ID: 28556483
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer.
Carol H; Boehm I; Reynolds CP; Kang MH; Maris JM; Morton CL; Gorlick R; Kolb EA; Keir ST; Wu J; Wozniak AE; Yang Y; Manfredi M; Ecsedy J; Wang J; Neale G; Houghton PJ; Smith MA; Lock RB
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1291-304. PubMed ID: 21448591
[TBL] [Abstract][Full Text] [Related]
15. The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients.
Kahl I; Mense J; Finke C; Boller AL; Lorber C; Győrffy B; Greve B; Götte M; Espinoza-Sánchez NA
J Cell Biochem; 2022 Mar; 123(3):581-600. PubMed ID: 35014077
[TBL] [Abstract][Full Text] [Related]
16. Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237.
Sloane DA; Trikic MZ; Chu ML; Lamers MB; Mason CS; Mueller I; Savory WJ; Williams DH; Eyers PA
ACS Chem Biol; 2010 Jun; 5(6):563-76. PubMed ID: 20426425
[TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β.
Ohishi J; Aoki M; Nabeshima K; Suzumiya J; Takeuchi T; Ogose A; Hakozaki M; Yamashita Y; Iwasaki H
BMC Cancer; 2013 May; 13():224. PubMed ID: 23642185
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 6 regulates mitotic spindle formation by controlling the T-loop phosphorylation state of Aurora A bound to its activator TPX2.
Zeng K; Bastos RN; Barr FA; Gruneberg U
J Cell Biol; 2010 Dec; 191(7):1315-32. PubMed ID: 21187329
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.
Byer SJ; Eckert JM; Brossier NM; Clodfelder-Miller BJ; Turk AN; Carroll AJ; Kappes JC; Zinn KR; Prasain JK; Carroll SL
Neuro Oncol; 2011 Jan; 13(1):28-41. PubMed ID: 21075781
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft model.
Mahller YY; Vaikunth SS; Currier MA; Miller SJ; Ripberger MC; Hsu YH; Mehrian-Shai R; Collins MH; Crombleholme TM; Ratner N; Cripe TP
Mol Ther; 2007 Feb; 15(2):279-86. PubMed ID: 17235305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
